ScholarLens Back to search
2005•Modern Medicine HealthRequires access

Observation of the curative effect of rosiglitazone combined with metformin in type 2 diabetes

Chang Xiao-fen

Open publisher page 0 citations

Abstract

Objective:To observe the curative effect of rosiglitazone combined with metformin in the treatment of type 2 diabetes.Methods:64 outpatients corresponding to type 2 diabetes were divided into two groups at random,with 32 cases in each group.The treatment group(group A) was treated with rosigilitazone tablets 4 mg orally once a day and metformin tablets 0.25 g three times a day,while the control group(group B) with metformin tablets 0.5g three times a day.The course of treatment in both groups was six weeks.Results:In group A,the blood glucose of the patients was changed before meal and two hours after meal compared with that of the patients before clinical observation,with significant difference(P0.05).However,there was no any change im group B(P0.05).Conclusion:The curative effect of rosiglitazone combined with melformin is far better than that only with metformin in type 2 diabetes.

About this research paper

What this paper is about

Objective:To observe the curative effect of rosiglitazone combined with metformin in the treatment of type 2 diabetes.Methods:64 outpatients corresponding to type 2 diabetes were divided into two groups at random,with 32 cases in each group.The treatment group(group A) was treated with rosigilitazone tablets 4 mg orally once a day and metformin tablets 0.25 g three times a day,while the control group(group B) with metformin tablets 0.5g three times a day.The course of treatment in both groups was six weeks.Results:In group A,the blood glucose of the patients was changed before meal and two hours after meal compared with that of the patients before clinical observation,with significant difference(P0.05).However,there was no any change im group B(P0.05).Conclusion:The curative effect of rosiglitazone combined with melformin is far better than that only with metformin in type 2 diabetes.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the curative effect of rosiglitazone combined with metformin in the treatment of type 2 diabetes.Methods:64 outpatients corresponding to type 2 diabetes were divided into two groups at random,with 32 cases in each group.The treatment group(group A) was treated with rosigilitazone tablets 4 mg orally once a day and metformin tablets 0.25 g three times a day,while the control group(group B) with metformin tablets 0.5g three times a day.The course of treatment in both groups was six weeks.Results:In group A,the blood glucose of the patients was changed before meal and two hours after meal compared with that of the patients before clinical observation,with significant difference(P0.05).However,there was no any change im group B(P0.05).Conclusion:The curative effect of rosiglitazone combined with melformin is far better than that only with metformin in type 2 diabetes.

Key concepts: Medicine, Metformin, Rosiglitazone, Type 2 diabetes, Internal medicine, Meal, Diabetes mellitus, Significant difference

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Observation of the curative effect of rosiglitazone combined with metformin in type 2 diabetes — Research Paper | ScholarLens